174 related articles for article (PubMed ID: 3967085)
1. The role of activated human platelets in prothrombin and factor X activation.
Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
[TBL] [Abstract][Full Text] [Related]
2. Changes in membrane phospholipid distribution during platelet activation.
Bevers EM; Comfurius P; Zwaal RF
Biochim Biophys Acta; 1983 Dec; 736(1):57-66. PubMed ID: 6418205
[TBL] [Abstract][Full Text] [Related]
3. Platelet procoagulant properties studied with snake venom prothrombin activators.
Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
[TBL] [Abstract][Full Text] [Related]
4. Development of procoagulant binding sites on the platelet surface.
Bevers EM; Rosing J; Zwaal RF
Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
[TBL] [Abstract][Full Text] [Related]
5. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
[TBL] [Abstract][Full Text] [Related]
6. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.
Rosing J; Bevers EM; Comfurius P; Hemker HC; van Dieijen G; Weiss HJ; Zwaal RF
Blood; 1985 Jun; 65(6):1557-61. PubMed ID: 3995186
[TBL] [Abstract][Full Text] [Related]
7. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH
Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766
[TBL] [Abstract][Full Text] [Related]
9. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
10. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187.
van Rijn J; Rosing J; van Dieijen G
Eur J Biochem; 1983 Jun; 133(1):1-10. PubMed ID: 6406226
[No Abstract] [Full Text] [Related]
11. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
[TBL] [Abstract][Full Text] [Related]
12. The effect of aggregation and release on platelet prothrombin-converting activity.
Cox AC; Inyangetor P; Esmon CT; White BN
Blood; 1979 Sep; 54(3):659-72. PubMed ID: 465734
[TBL] [Abstract][Full Text] [Related]
13. Membrane phospholipids are the major determinant of the binding site for factor X activating--and prothrombinase complexes at the surface of human platelets.
Bevers EM; Rosing J; Zwaal RF
Agents Actions Suppl; 1986; 20():69-75. PubMed ID: 3468783
[No Abstract] [Full Text] [Related]
14. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
Tracy PB; Eide LL; Mann KG
J Biol Chem; 1985 Feb; 260(4):2119-24. PubMed ID: 3972783
[TBL] [Abstract][Full Text] [Related]
15. Platelet membrane involvement in blood coagulation.
Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
[TBL] [Abstract][Full Text] [Related]
16. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.
Neuenschwander P; Jesty J
Blood; 1988 Nov; 72(5):1761-70. PubMed ID: 3140913
[TBL] [Abstract][Full Text] [Related]
17. Enhanced prothrombin-converting activity and factor Xa binding of platelets activated by the alternative complement pathway.
Ozge-Anwar AH; Freedman JJ; Senyi AF; Cerskus AL; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):221-8. PubMed ID: 6610438
[TBL] [Abstract][Full Text] [Related]
18. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
20. The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.
Mounier C; Franken PA; Verheij HM; Bon C
Eur J Biochem; 1996 May; 237(3):778-85. PubMed ID: 8647125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
